Skip to Main Content
Donate

This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.

This is a test.

Ensuring progress continues for generations to come

This is a test.

Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer team up to improve access to vital resources

This is a test.

Advocacy in action: Making game-changing PARP Inhibitors accessible for women in Prince Edward Island

This is a test.

Canadian innovation in ovarian cancer research can save the lives of women in Canada and around the world

This is a test.

CEO Blog: It’s time to be bold

This is a test.

Clinical Trial: Targeting the targets – investigating an innovative chemotherapy alternative

This is a test.

Clinical Trial: New biomarkers, improved treatment pathways

This is a test.

Volunteers recognized for their impact: The Peggy Truscott Award of Hope

This is a test.

Research knows no bounds

This is a test.

Learning and Connecting – 2022 National Symposium